002019 亿帆医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.365-6.4502.2053.28012.151
总资产报酬率 ROA (%)3.070-4.5841.5482.3398.531
投入资产回报率 ROIC (%)3.380-5.0541.7072.5919.643

边际利润分析
销售毛利率 (%)47.64747.84048.63541.46946.477
营业利润率 (%)9.943-21.6983.7484.81320.083
息税前利润/营业总收入 (%)11.272-19.9164.6656.41921.258
净利润/营业总收入 (%)7.977-21.7713.3125.49417.247

收益指标分析
经营活动净收益/利润总额(%)84.746-3.012118.914106.87889.171
价值变动净收益/利润总额(%)-1.8001.733-11.250-2.1300.642
营业外收支净额/利润总额(%)0.370-1.5748.249-0.668-0.356

偿债能力分析
流动比率 (X)1.3161.4861.6781.5581.647
速动比率 (X)0.9591.0621.3001.2691.373
资产负债率 (%)31.93628.21627.08327.8710.250
带息债务/全部投入资本 (%)21.75018.59319.21419.67315.838
股东权益/带息债务 (%)348.999425.239404.494391.875511.385
股东权益/负债合计 (%)215.497255.052259.376251.733290.328
利息保障倍数 (X)8.724-13.7728.0483.91917.052

营运能力分析
应收账款周转天数 (天)86.164101.414105.96885.02265.015
存货周转天数 (天)133.210149.262136.53687.02873.610